Literature DB >> 6403866

A novel type of aberrant recombination in immunoglobulin genes and its implications for V-J joining mechanism.

J Höchtl, H G Zachau.   

Abstract

Functional kappa light chain genes are formed during B-lymphocyte differentiation by the joining of initially separate V and J gene segments. It has been suggested that the intervening DNA is deleted, however the recent reports of what appear to be the reciprocal products of V and J recombination (back-to-back conserved V and J flanking sequences, called f-fragments) in DNA from mature lymphocytes make a simple deletion model unlikely. An alternative scheme involving unequal sister chromatid exchange has been proposed, supported by the evidence that the f-fragments seem to have segregated from the chromosome carrying the reciprocal complete kappa light chain gene (this and other schemes are briefly reviewed in ref. 8). We report here the analysis of a mouse myeloma (MOPC 41), in which a productive (kappa+) and a non-productive (kappa-) rearrangement has occured, which may help to clarify the mechanism of V-J joining. The aberrant rearrangement has led to the joining of a J1 gene segment to a sequence unrelated to any V gene (L10), and which in the germ line is flanked by a sequence resembling a V region recombination signal sequence. In this case no segregation of the reciprocal recombination products (kappa-41 and f41), which is a required step in sister chromatid exchange models, has taken place. An inversion model provides the simplest explanation of this J rearrangement.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403866     DOI: 10.1038/302260a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  28 in total

1.  Generation of a variant t(2;8) translocation of Burkitt's lymphoma by site-specific recombination via the kappa light-chain joining signals.

Authors:  P Hartl; M Lipp
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

2.  Rapid assay for extrachromosomal homologous recombination in monkey cells.

Authors:  J Rubnitz; S Subramani
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

3.  Complete nucleotide sequences of three VH genes in Caiman, a phylogenetically ancient reptile: evolutionary diversification in coding segments and variation in the structure and organization of recombination elements.

Authors:  G W Litman; K Murphy; L Berger; R Litman; K Hinds; B W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Double recombination of a single immunoglobulin kappa-chain allele: implications for the mechanism of rearrangement.

Authors:  R M Feddersen; B G Van Ness
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

5.  Reciprocal recombination products of VK-JK joining reactions in human lymphoid cell lines.

Authors:  S M Deev; G Combriato; H G Klobeck; H G Zachau
Journal:  Nucleic Acids Res       Date:  1987-01-12       Impact factor: 16.971

6.  An excision event that may depend on patchy homology for site specificity.

Authors:  D Bourgaux-Ramoisy; D Gendron; P Chartrand; P Bourgaux
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

7.  Molecular basis for the aberrant expression of T cell antigens in postthymic T cell malignancies.

Authors:  I J Su; S P Balk; M E Kadin
Journal:  Am J Pathol       Date:  1988-08       Impact factor: 4.307

8.  Abnormal recombination products result from aberrant DNA rearrangement of the human T-cell antigen receptor beta-chain gene.

Authors:  A D Duby; J G Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

9.  Extrachromosomal and chromosomal gene conversion in mammalian cells.

Authors:  J Rubnitz; S Subramani
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

10.  Simple sequences are ubiquitous repetitive components of eukaryotic genomes.

Authors:  D Tautz; M Renz
Journal:  Nucleic Acids Res       Date:  1984-05-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.